v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2022     123,925        
Beginning balance at Dec. 31, 2022 $ (158,223)   $ 1,240 $ 6,454,540 $ (44,654) $ (6,569,349)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options, net of tax withholdings (in shares)     1,162        
Exercise of common stock options, net of tax withholdings 114,249   $ 12 114,237      
Issuance of common stock under equity plans (in shares)     707        
Issuance of common stock under equity plans 16,428   $ 7 16,421      
Stock-based compensation expense 225,865     225,865      
Other comprehensive income (loss) 21,279       21,279    
Net income (loss) (440,242)         (440,242)  
Ending balance (in shares) at Dec. 31, 2023     125,794        
Ending balance at Dec. 31, 2023 (220,644)   $ 1,259 6,811,063 (23,375) (7,009,591)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options, net of tax withholdings (in shares)     2,504        
Exercise of common stock options, net of tax withholdings 284,281   $ 25 284,256      
Issuance of common stock under equity plans (in shares)     996        
Issuance of common stock under equity plans 17,434   $ 9 17,425      
Stock-based compensation expense 275,317     275,317      
Other comprehensive income (loss) (11,143)       (11,143)    
Net income (loss) $ (278,157)         (278,157)  
Ending balance (in shares) at Dec. 31, 2024 129,294   129,294        
Ending balance at Dec. 31, 2024 $ 67,088 $ 271,477 $ 1,293 7,388,061 (34,518) (7,287,748) $ 271,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options, net of tax withholdings (in shares)     1,836        
Exercise of common stock options, net of tax withholdings 229,697   $ 18 229,679      
Issuance of common stock under equity plans (in shares)     1,246        
Issuance of common stock under equity plans 20,497   $ 13 20,484      
Stock-based compensation expense 352,745     352,745      
Repurchase of 1.00% Convertible Senior Notes due 2027 445,185     445,185      
Purchase of capped calls related to 0.00% Convertible Senior Notes due 2028 (35,311)     (35,311)      
Other comprehensive income (loss) 14,421       14,421    
Net income (loss) $ 313,747         313,747  
Ending balance (in shares) at Dec. 31, 2025 132,376   132,376        
Ending balance at Dec. 31, 2025 $ 789,176   $ 1,324 $ 7,510,473 $ (20,097) $ (6,702,524)